Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients
혈액학적 환자에서 anti-SARS-CoV-2 mRNA 백신접종에 대한 혈청학적 반응 평가
Article
[키워드] Administered
anti-SARS-CoV-2
anti-SARS-CoV-2 IgG
anti-SARS-CoV-2 vaccination
Anti-spike
anti-Spike IgG
anti-spike IgG level
antibody
Antibody titer
association
Cell
Cohort
cohort of patient
Concentration
control arm
control group
Cutoff
demographic variable
difference
drug
Effect
evaluated
greater
health worker
healthy
healthy subjects
hematological
Hematological malignancies
Hematological malignancy
heterogeneous
highest
identify
IgG
IgG titer
immune system
immunoassay
Immunocompromised patients
Immunosuppression
implication
inhibitor
Italy
leukemia
Microparticle
molecular
mRNA
mRNA vaccination
mRNA vaccine
onco-hematology.
parameter
pathology
Patient
patients
performed
Predictive
reached
reduced
reported
SARS-CoV-2
SARS-CoV-2 antibody
second dose
seroconversion rate
serological response
shown
significantly lower
spike IgG
statistical significance
steroid
stratified
Surveillance
the mean
the patient
Therapies
therapy
treated
tyrosine
underlying disease
vaccination
Vaccine
was reduced
[DOI] 10.3389/fimmu.2022.892331 PMC 바로가기 [Article Type] Article
[DOI] 10.3389/fimmu.2022.892331 PMC 바로가기 [Article Type] Article